Hpb

SCIE

國際簡稱：HPB 參考譯名：血紅蛋白

主要研究方向：GASTROENTEROLOGY & HEPATOLOGY-SURGERY 非預警期刊審稿周期：約1月

《血紅蛋白》(Hpb)是一本由John Wiley and Sons Inc.出版的以GASTROENTEROLOGY & HEPATOLOGY-SURGERY為研究特色的國際期刊，發表該領域相關的原創研究文章、評論文章和綜述文章，及時報道該領域相關理論、實踐和應用學科的最新發現，旨在促進該學科領域科學信息的快速交流。該期刊是一本未開放期刊，近三年沒有被列入預警名單。

3區中科院分區
Q1 JCR分區
172 年發文量
2.7 IF影響因子
未開放 是否OA
62 H-index
1998 創刊年份
12 issues/year 出版周期
English 出版語言

HPB is an international forum for clinical, scientific and educational communication.

Twelve issues a year bring the reader leading articles, expert reviews, original articles, images, editorials, and reader correspondence encompassing all aspects of benign and malignant hepatobiliary disease and its management. HPB features relevant aspects of clinical and translational research and practice.

Specific areas of interest include HPB diseases encountered globally by clinical practitioners in this specialist field of gastrointestinal surgery. The journal addresses the challenges faced in the management of cancer involving the liver, biliary system and pancreas. While surgical oncology represents a large part of HPB practice, submission of manuscripts relating to liver and pancreas transplantation, the treatment of benign conditions such as acute and chronic pancreatitis, and those relating to hepatobiliary infection and inflammation are also welcomed. There will be a focus on developing a multidisciplinary approach to diagnosis and treatment with endoscopic and laparoscopic approaches, radiological interventions and surgical techniques being strongly represented. HPB welcomes submission of manuscripts in all these areas and in scientific focused research that has clear clinical relevance to HPB surgical practice.

HPB aims to help its readers - surgeons, physicians, radiologists and basic scientists - to develop their knowledge and practice. HPB will be of interest to specialists involved in the management of hepatobiliary and pancreatic disease however will also inform those working in related fields.

Abstracted and Indexed in:

MEDLINE?

EMBASE

PubMed

Science Citation Index Expanded

Academic Search (EBSCO)

HPB is owned by the International Hepato-Pancreato-Biliary Association (IHPBA) and is also the official Journal of the American Hepato-Pancreato-Biliary Association (AHPBA), the Asian-Pacific Hepato Pancreatic Biliary Association (A-PHPBA) and the European-African Hepato-Pancreatic Biliary Association (E-AHPBA).

[ 查看全部 ]

投稿咨詢加急咨詢

Hpb期刊信息

ISSN：1365-182X
出版語言：English
是否OA：未開放
E-ISSN：1477-2574
出版地區：ENGLAND
是否預警：否
出版商：John Wiley and Sons Inc.
出版周期：12 issues/year
創刊時間：1998
開源占比：0.1
Gold OA文章占比：75.97%
OA被引用占比：0.0421...
出版國人文章占比：0.08
出版撤稿占比：0
研究類文章占比：87.21%

Hpb CiteScore評價數據（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指數

5.6

1.141

1.15

學科類別	分區	排名	百分位
大類：Medicine 小類：Gastroenterology	Q2	44 / 167	73%
大類：Medicine 小類：Hepatology	Q2	30 / 82	64%

名詞解釋：CiteScore 是衡量期刊所發表文獻的平均受引用次數，是在 Scopus 中衡量期刊影響力的另一個指標。當年CiteScore 的計算依據是期刊最近4年（含計算年度）的被引次數除以該期刊近四年發表的文獻數。例如，2022年的 CiteScore 計算方法為：2022年的 CiteScore =2019-2022年收到的對2019-2022年發表的文件的引用數量÷2019-2022年發布的文獻數量注：文獻類型包括：文章、評論、會議論文、書籍章節和數據論文。

Hpb中科院評價數據

中科院 2023年12月升級版

Top期刊	綜述期刊	大類學科		小類學科
否	否	醫學	3區	SURGERY 外科 GASTROENTEROLOGY & HEPATOLOGY 胃腸肝病學	3區 4區

中科院 2022年12月升級版

Top期刊	綜述期刊	大類學科		小類學科
否	否	醫學	3區	GASTROENTEROLOGY & HEPATOLOGY 胃腸肝病學 SURGERY 外科	3區 3區

中科院 2021年12月舊的升級版

Top期刊	綜述期刊	大類學科		小類學科
否	否	醫學	3區	GASTROENTEROLOGY & HEPATOLOGY 胃腸肝病學 SURGERY 外科	3區 3區

中科院 2021年12月基礎版

Top期刊	綜述期刊	大類學科		小類學科
否	否	醫學	3區	GASTROENTEROLOGY & HEPATOLOGY 胃腸肝病學 SURGERY 外科	4區 3區

中科院 2021年12月升級版

Top期刊	綜述期刊	大類學科		小類學科
否	否	醫學	3區	GASTROENTEROLOGY & HEPATOLOGY 胃腸肝病學 SURGERY 外科	3區 3區

中科院 2020年12月舊的升級版

Top期刊	綜述期刊	大類學科		小類學科
否	否	醫學	2區	SURGERY 外科 GASTROENTEROLOGY & HEPATOLOGY 胃腸肝病學	2區 3區

Hpb JCR評價數據（2023-2024年最新版）

按JIF指標學科分區	收錄子集	分區	排名	百分位
學科：GASTROENTEROLOGY & HEPATOLOGY	SCIE	Q2	64 / 143	55.6%
學科：SURGERY	SCIE	Q1	56 / 290	80.9%

按JCI指標學科分區	收錄子集	分區	排名	百分位
學科：GASTROENTEROLOGY & HEPATOLOGY	SCIE	Q1	34 / 143	76.57%
學科：SURGERY	SCIE	Q2	74 / 290	74.66%

Hpb歷年數據統計

影響因子

中科院分區

Hpb中國學者發文選摘

1、Preoperative prediction model of microvascular invasion in patients with hepatocellular carcinoma
Author: Zhang, Jianfeng; Zeng, Fanxin; Jiang, Shijie; Tang, Hui; Zhang, Jian

Journal: HPB. 2023; Vol. 25, Issue 1, pp. 45-53. DOI: 10.1016/j.hpb.2022.08.007
2、Prospective validation of the Eastern Staging in predicting survival after surgical resection for patients with hepatocellular carcinoma: a multicenter study from China
Author: Yang, Shun-Chao; Liang, Lei; Wang, Ming-Da; Wang, Xian -Ming; Gu, Li -Hui; Lin, Kong-Ying; Zhou, Ya-Hao; Chen, Ting-Hao; Gu, Wei-Min; Li, Jie; Wang, Hong; Chen, Zhong; Li, Chao; Yao, Lan-Qing; Diao, Yong-Kang; Sun, Li -Yang; Zhang, Cheng-Wu; Zeng, Yong-Yi; Lau, Wan Yee; Huang, Dong-Sheng; Shen, Feng; Yang, Tian

Journal: HPB. 2023; Vol. 25, Issue 1, pp. 81-90. DOI: 10.1016/j.hpb.2022.09.002
3、Beyond successful hemostasis: CT findings and organ failure predict postoperative death in patients suffering from post-pancreatoduodenectomy hemorrhage
Author: Yang, Jie; Chen, Yonghua; Liu, Xubao; Zheng, Zhenjiang; Wang, Xing; Li, Yichen; Tan, Chunlu

Journal: HPB. 2023; Vol. 25, Issue 2, pp. 252-259. DOI: 10.1016/j.hpb.2022.11.004
4、Application of hazard functions to investigate recurrence after curative-intent resection for hepatocellular carcinoma
Author: Lima, Henrique A.; Alaimo, Laura; Brown, Zachary J.; Endo, Yutaka; Moazzam, Zorays; Tsilimigras, Diamantis I.; Shaikh, Chanza; Resende, Vivian; Guglielmi, Alfredo; Ratti, Francesca; Aldrighetti, Luca; Marques, Hugo P.; Soubrane, Olivier; Lam, Vincent; Poultsides, George A.; Popescu, Irinel; Alexandrescu, Sorin; Martel, Guillaume; Hugh, Tom; Endo, Itaru; Shen, Feng; Pawlik, Timothy M.

Journal: HPB. 2023; Vol. 25, Issue 2, pp. 260-268. DOI: 10.1016/j.hpb.2022.11.008
5、Analysis of conditional survival in primary hepatocellular carcinoma after narrow-margin hepatectomy: a large- sample, dual-centre, retrospective study
Author: Kong, Jie; Huang, Tingfeng; Zhang, Jianxi; Tang, Shichuan; Liu, Hongzhi; Liu, Jingfeng; Zeng, Yongyi

Journal: HPB. 2023; Vol. 25, Issue 2, pp. 179-188. DOI: 10.1016/j.hpb.2022.08.005
6、Predictive risk-score model to select patients with intrahepatic cholangiocarcinoma for adjuvant chemotherapy
Author: Endo, Yutaka; Moazzam, Zorays; Alaimo, Laura; Lima, Henrique A.; Munir, Muhammad M.; Shaikh, Chanza F.; Guglielmi, Alfredo; Aldrighetti, Luca; Weiss, Matthew; Bauer, Todd W.; Alexandrescu, Sorin; Poultsides, George A.; Kitago, Minoru; Maithel, Shishir K.; Marques, Hugo P.; Martel, Guillaume; Pulitano, Carlo; Shen, Feng; Cauchy, Francois; Koerkamp, Bas G.; Endo, Itaru; Pawlik, Timothy M.

Journal: HPB. 2023; Vol. 25, Issue 2, pp. 229-238. DOI: 10.1016/j.hpb.2022.10.011
7、Preoperative risk score (PreopScore) to predict overall survival after resection for hepatocellular carcinoma
Author: Endo, Yutaka; Lima, Henrique A.; Alaimo, Laura; Moazzam, Zorays; Brown, Zachary; Shaikh, Chanza F.; Ratti, Francesca; Marques, Hugo P.; Soubrane, Olivier; Lam, Vincent; Poultsides, George A.; Popescu, Irinel; Alexandrescu, Sorin; Martel, Guillaume; Workneh, Aklile; Guglielmi, Alfredo; Hugh, Tom; Aldrighetti, Luca; Shen, Feng; Endo, Itaru; Pawlik, Timothy M.

Journal: HPB. 2023; Vol. 25, Issue 3, pp. 353-362. DOI: 10.1016/j.hpb.2022.12.009
8、Efficiency of percutaneous transhepatic cholangioscopy in the treatment of biliary complications after liver transplantation
Author: Yasen, Aimaiti; Feng, Jun; Liang, Run-Bin; Zhu, Can-Hua; Li, Jun; Liu, An-Zhong; Liu, Yan-Min; Wang, Guo-Ying

Journal: HPB. 2023; Vol. 25, Issue 4, pp. 463-471. DOI: 10.1016/j.hpb.2023.01.010